For: | Yang T, Chao K, Zhu X, Wang XD, Chan S, Guan YP, Mao J, Li P, Guan SX, Xie W, Gao X, Huang M. Early proactive monitoring of DNA-thioguanine in patients with Crohn’s disease predicts thiopurine-induced late leucopenia in NUDT15/TPMT normal metabolizers. World J Gastroenterol 2024; 30(12): 1751-1763 [PMID: 38617736 DOI: 10.3748/wjg.v30.i12.1751] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v30/i12/1751.htm |
Number | Citing Articles |
1 |
Ahmed B. Bayoumy, A. R. Ansari, C. J. J. Mulder, K. Schmiegelow, Timothy Florin, N. K. H. De Boer. Innovating Thiopurine Therapeutic Drug Monitoring: A Systematic Review and Meta-Analysis on DNA-Thioguanine Nucleotides (DNA-TG) as an Inclusive Biomarker in Thiopurine Therapy. Clinical Pharmacokinetics 2024; 63(8): 1089 doi: 10.1007/s40262-024-01393-0
|
2 |
Ahmed Bayoumy Bayoumy, Ludovicus Jozef Johannes Derijks, Nanne Klaas Hendrik de Boer. DNA-Thioguanine (DNA-TG) Is a Promising Novel Method to Predict Adverse Events to Thiopurine in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2024; doi: 10.1093/ibd/izae234
|